Masaud S. Shah
Suwon, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 60 publications
Correction: Peptide‑based therapeutics targeting the SLC39A14‑PIWIL2 fusion in hepatocellular carcinoma.
Journal: Genomics & informatics
Published: April 17, 2026
Engineered flower-like core-double-shell upconversion nanoarchitectures for ultrasensitive activatable FRET imaging of cathepsin B in vitro and in vivo.
Journal: Talanta
Published: April 02, 2026
Corrigendum to "A peptide derived from the core β-sheet region of TIRAP decoys TLR4 and reduces inflammatory and autoimmune symptoms in murine models" [eBioMedicine 52 (2020) 102645].
Journal: EBioMedicine
Published: October 30, 2025
Peptide‑based therapeutics targeting the SLC39A14‑PIWIL2 fusion in hepatocellular carcinoma.
Journal: Genomics & informatics
Published: July 26, 2025
BIGPN: Biologically informed graph propagational network for plasma proteomic profiling of neurodegenerative biomarkers.
Journal: Artificial intelligence in medicine
Published: May 03, 2025
Structural insights into antibody-based immunotherapy for hepatocellular carcinoma.
Journal: Genomics & informatics
Published: October 24, 2024
Aspirin vs. ibuprofen: unveiling the distinct cyclooxygenase-1/2 behaviour and dual efficacy of their synthesized analogues via molecular modeling and in vitro biological assessment.
Journal: RSC medicinal chemistry
Published: September 25, 2024
Leveraging deep transfer learning and explainable AI for accurate COVID-19 diagnosis: Insights from a multi-national chest CT scan study.
Journal: Computers in biology and medicine
Published: August 29, 2024
Pan-Variant SARS-CoV-2 Vaccines Induce Protective Immunity by Targeting Conserved Epitopes.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: August 19, 2024
Long Non-coding RNA TPRG1-AS1 Interacts With CLTC in Liver Cancer Cells.
Journal: Anticancer research
Published: August 09, 2024
Challenges and considerations in multi-epitope vaccine design surrounding toll-like receptors.
Journal: Trends in pharmacological sciences
Published: July 12, 2024
RRM2 Is a CTNNB1 Transport Regulator Promoting Colon Cancer Progression.
Journal: Anticancer research
Published: April 03, 2024
Last Updated: 09/26/2026